Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
An independent, investigator-initiated peer-reviewed study found the ReWalk Personal Exoskeleton was used at home for a median of 33 months by people with chronic paraplegia, with no reported falls or exoskeleton-related fractures. Utilization was sustained, with 6 of 7 participants recording more than 3,000 steps per month, and users reported high satisfaction plus improvements in quality of life, mental health, and pain.
Key figures
- Drug Name
- ReWalk Personal Exoskeleton
- Median sus score
- 70 out of 100
- Use range months
- 20 to 45 months
- Study participants
- 7
- Median months of use
- 33
- Median monthly steps threshold
- 3000
- Median quest satisfaction score
- 4.2 out of 5
- Median six minute walk distance meters
- 129
- Median walking speed meters per second
- 0.43
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.